About Pyxis Oncology, Inc. 
Pyxis Oncology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 22 Schemes (9.4%)
Foreign Institutions
Held by 36 Foreign Institutions (3.66%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
Pharmaceuticals & Biotechnology
USD 103 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.11
-110.68%
1.50






